Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2021308162-A1 · Oct 7, 2021 · US
This page is not indexed by search engines while we improve data quality.
Hackam David J patents
Hackam David J is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hackam David J |
| Total patents | 13 |
| First publication | Feb 26, 2015 |
| Latest publication | Oct 7, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-10933077-B2 · Mar 2, 2021 · US
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2019374562-A1 · Dec 12, 2019 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-10300083-B2 · May 28, 2019 · US
Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
US-2019070168-A1 · Mar 7, 2019 · US
Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
US-10172848-B2 · Jan 8, 2019 · US
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2017095493-A1 · Apr 6, 2017 · US
Oral therapy of necrotizing enterocolitis
US-9562066-B2 · Feb 7, 2017 · US
Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists
US-9549980-B2 · Jan 24, 2017 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-9532999-B2 · Jan 3, 2017 · US
Recent patents
Latest publications not already listed above.
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2015250809-A1 · Sep 10, 2015 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-9072760-B2 · Jul 7, 2015 · US
Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4 associated disorders
US-2015056217-A1 · Feb 26, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/7024 | 8 |
| A61K31/7034 | 8 |
| A61K31/7008 | 8 |
| A61K31/7028 | 8 |
| A61K31/351 | 8 |